DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Delayed Deutsche Boerse AG 13:50:30 2024-05-31 EDT | ||
| 195.9 EUR | +1.44% |
|
| 1 month | +0.93% | ||
| 3 months | +1.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 195.9 | +1.44% |
| 24-05-30 | 193.2 | +0.79% |
| 24-05-29 | 191.6 | +0.11% |
| 24-05-28 | 191.4 | -0.39% |
| 24-05-27 | 192.2 | -0.11% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 01:50 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5USB |
| ISIN | DE000VM5USB5 |
| Date issued | 2023-11-22 |
| Maturity | 2024-09-20 (110 Days) |
| Parity | 1 : 1 |
| Emission price | 188.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 198.8 € |
|---|---|
| Lowest since issue | 175.3 € |
| Spread | 1.57 € |
| Spread % | 0.79% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
